Kort om
Spesialiserer seg på problemstillinger knyttet til ansvarlig kunnskapsbasert beslutningstaking med fokus på risiko og sikkerhet ved medisiner og ny bioteknologi, både fra et praktisk, metodisk og filosofisk perspektiv. Jobber tverrfaglig mellom vitenskapelig bevis, praksis og filosofi. Forskning inkluderer årsaksvurdering i legemiddelsikkerhet, klinisk resonnement, analyse av ekspertens uenighet.
Forskningsgrupper
Forskningsprosjekter
-
Kausalitet, kompleksitet og evidens i pharmacovigilance
Å oppdage ukjende biverknader av marknadsførte legemiddel er utfordrande og krev forbetra metodar for å vurdere årsakssamanheng, og dessutan betre klinisk evidensgrunnlag.
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Anjum, Rani Lill; Price, Christine;
Rocca, Elena
(2024).
When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring.
Social Epistemology.
https://doi.org/10.1080/02691728.2024.2400079
Leblanc, Marissa Erin; Williamson, Jon; De Pretis, Francesco; Landes, Jurgen;
Rocca, Elena
(2024).
Individual consent in cluster randomised trials for non-pharmaceutical interventions: going beyond the Ottawa statement.
9 s.
Critical Public Health.
Vol. 34.
https://doi.org/10.1080/09581596.2024.2338074
Anjum, Rani Lill;
Rocca, Elena
(2024).
A Dispositional Account of Causation: Implications for the Biological Sciences.
Yafeng, Shan; Shan, Yafeng (Red.).
Alternative Approaches to Causation: Beyond Difference-Making and Mechanism. s. 95-121.
Oxford University Press.
https://doi.org/https://doi.org/10.1093/oso/978019
Anjum, Rani Lill; Chandler, Rebecca;
Rocca, Elena
(2022).
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.
8 s.
Pharmaceutical Medicine.
Vol. 36.
https://doi.org/10.1007/s40290-022-00429-9
Pérez-González, Saul;
Rocca, Elena
(2022).
Evidence of Biological Mechanisms and Health Predictions: An Insight into Clinical Reasoning.
16 s.
Perspectives in biology and medicine.
Vol. 65.
https://doi.org/10.1353/pbm.2022.0005
Rocca, Elena
; Grundmark, Birgitta
(2021).
Monitoring the Safety of Medicines and Vaccines in Times of Pandemic: Practical, Conceptual, and Ethical Challenges in Pharmacovigilance.
19 s.
Argumenta.
Vol. 7.
https://doi.org/10.14275/2465-2334/202113.roc
Rocca, Elena
; Gauffin, Oskar; Savage, Ruth; Vidlin, Sara Hedfors; Grundmark, Birgitta
(2021).
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
Drug Safety.
Vol. 44.
https://doi.org/10.1007/s40264-021-01091-x
Anjum, Rani Lill; Copeland, Samantha Marie;
Rocca, Elena
(2020).
Introduction: Why Is Philosophy Relevant for Clinical Practice?.
Anjum, Rani Lill; Copeland, Samantha Marie; Rocca, Elena (Red.).
Rethinking Causality, Complexity and Evidence for the Unique Patient. A CauseHealth Resource for Healthcare Professionals and the Clinical Encounter. s. 3-11.
Springer Nature.
https://doi.org/10.1007/978-3-030-41239-5_1
Rocca, Elena
; Anjum, Rani Lill; Mumford, Stephen D
(2020).
Causal Insights from Failure: Post-Marketing Risk Assessment of Drugs as a Way to Uncover Causal Mechanisms.
LaCaze, Adam; Osimani, Barbara (Red.).
Uncertainty in Pharmacology. Epistemology, Methods and Decisions.. s. 39-57.
Springer.
https://doi.org/10.1007/978-3-030-29179-2_2
Anjum, Rani Lill; Copeland, Samantha Marie;
Rocca, Elena
(2020).
Rethinking Causality, Complexity and Evidence for the Unique Patient. A CauseHealth Resource for Healthcare Professionals and the Clinical Encounter.
ISBN: 978-3-030-41239-5.
241 s.
Springer Nature.
https://link.springer.com/book/10.1007/978-3-030-4
